✦ LIBER ✦

Low-molecular-weight heparin biosimilars: potential implications for clinical practice

✍ Scribed by Nandurkar, H.; Chong, B.; Salem, H.; Gallus, A.; Ferro, V.; McKinnon, R.

Book ID: 121867624
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 101 KB
Volume: 44
Category: Article
ISSN: 1444-0903
DOI: 10.1111/imj.12417

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low molecular weight heparin biosimilars

Low molecular weight heparin biosimilars: how much similarity for how much clinical benefit?

✍ Ludovic Drouet 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 134 KB

4 Clinical potential of low molecular we

4 Clinical potential of low molecular weight heparins

✍ Mark N. Levine; Jack Hirsh 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 806 KB

Low Molecular Weight Heparin Therapy for

Low Molecular Weight Heparin Therapy for Percutaneous Coronary Intervention: A Practice in Evolution

✍ Joseph K. Choo; Dean J. Kereiakes 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 736 KB

Thromboprophylaxis with the Low-Molecula

Thromboprophylaxis with the Low-Molecular-Weight Heparin Bemiparin Sodium in Elderly Medical Patients in Usual Clinical Practice

✍ Dr Leocadio Rodríguez-Mañas, Ricardo Gómez-Huelgas, Fernando Veiga-Fernández, Ge 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 139 KB

Rationale for development of low-molecul

Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis

✍ Jack Hirsh 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 933 KB

US Food and Drug Administration approval

US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins

✍ Marc Cohen; Walter P. Jeske; Jose C. Nicolau; Gilles Montalescot; Jawed Fareed 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 489 KB